SAMANTHA FRANZ: Open Payments
NPI 1093768947 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,062 in 150 payments from 19 companies in 2025. Trend: 2023 $2,864 · 2024 $3,038 · 2025 $3,062
Food & beverage: $3,062
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $473 |
| ABBVIE INC. | 33 | $467 |
| Novo Nordisk Inc | 17 | $453 |
| AstraZeneca Pharmaceuticals LP | 13 | $361 |
| PFIZER INC. | 19 | $310 |
| Amgen Inc. | 14 | $188 |
| Kowa Pharmaceuticals America, Inc. | 13 | $145 |
| GlaxoSmithKline, LLC. | 6 | $130 |
| Lundbeck LLC | 5 | $96 |
| Exact Sciences Corporation | 3 | $70 |
Products named: MOUNJARO, FARXIGA, QULIPTA, Ozempic, NURTEC ODT, UBRELVY, ZORYVE, ZEPBOUND.
Industry payments across VA — which companies pay providers there.
